<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:mpath ids='MPATH_458'>Normal</z:mpath> prothrombin time (PT) and partial thromboplastin time (PTT) are recommended for administration of recombinant tissue-plasminogen activator (rt-PA) in <z:hpo ids='HP_0001297'>stroke</z:hpo>, but waiting for results can delay use </plain></SENT>
<SENT sid="1" pm="."><plain>We examined the charts of 365 <z:hpo ids='HP_0001297'>stroke</z:hpo> patients to assess predetermined risk factors associated with elevated PT/PTT </plain></SENT>
<SENT sid="2" pm="."><plain>Elevated PT/PTT can be predicted in patients taking <z:chebi fb="8" ids="10033">warfarin</z:chebi> or <z:chebi fb="5" ids="28304">heparin</z:chebi>/heparinoid or on hemodialysis, according to emergency department triage, with 100% sensitivity and 94.7% specificity </plain></SENT>
<SENT sid="3" pm="."><plain>These results could be applied to rt-PA candidates and reduce potential delays </plain></SENT>
</text></document>